← Back to Clinical Trials
Recruiting NCT06571032

NCT06571032 Electroencephalography in the Management of Neuroelectric Stimulation in Patients With Severe Traumatic Brain Injuries

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06571032
Status Recruiting
Phase
Sponsor RenJi Hospital
Condition Brain Injuries
Study Type OBSERVATIONAL
Enrollment 50 participants
Start Date 2024-08-15
Primary Completion 2025-08-14

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 50 participants in total. It began in 2024-08-15 with a primary completion date of 2025-08-14.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational retrospective study is to evaluate the electroencephalography (EEG)'s poficiency in the treatment of neuroelectric stimulation in patients with severe traumatic brain injuries (TBI). The main questions it aims to answer are: 1. Whether EEG of patients with severe TBI will change after they receiving neuroelectrial stimulation? If yes, how does it change? 2. How can EEG be used to evaluate the condition of patients with severe TBI?

Eligibility Criteria

Inclusion Criteria: * 7 days after severe traumatic brain injuries (GCS score 3-8); * Over 18 years old, regardless of gender; * The patient's legal representative is informed and voluntarily signs the consent form. Exclusion Criteria: * Unstable vital signs; * History of mental disorders or neurodegenerative diseases; * Uncontrolled epilepsy; * Severe arrhythmias or patients with implanted cardiac pacemakers; * Various conditions that interfere with scalp EEG collection; * Pregnant women.

Frequently Asked Questions

Who can join the NCT06571032 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Brain Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06571032 currently recruiting?

Yes, NCT06571032 is actively recruiting participants. Visit ClinicalTrials.gov or contact RenJi Hospital to inquire about joining.

Where is the NCT06571032 trial being conducted?

This trial is being conducted at Shanghai, China.

Who is sponsoring the NCT06571032 clinical trial?

NCT06571032 is sponsored by RenJi Hospital. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology